by The global atherectomy devices market size was estimated to be around US$ 765.49 million in 2023 and is projected to reach US$ 1,512.89 million by 2033, indicating a CAGR of 7.05% from 2024 to 2033.
Key Points
- North America led the market with the biggest market share of 45% in 2023.
- Asia Pacific is projected to expand at the fastest rate during the forecast period of 2024-2033.
- By device type, the drug-coated balloons (DCBs) segment held the largest share of the market in 2023.
- By device type, the intravascular ultrasound (IVUS) catheter segment is expected to show the fastest growth.
- By application type, the peripheral artery disease segment held the dominating share of the market in 2023.
- By application type, the coronary artery disease segment represents another highly influential segment for the forecast period.
- By end-user, the cardiac catheterization labs segment held the dominating share of the market in 2023.
- By end-user, the interventional radiology departments segment is expected to witness a significant rate of expansion during the forecast period.
The market research report on the atherectomy devices market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of atherectomy devices products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.
Get a Sample: https://www.precedenceresearch.com/sample/3901
Atherectomy Devices Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 7.05% |
| Global Market Size in 2023 | USD 765.49 Million |
| Global Market Size by 2033 | USD 1,512.89 Million |
| U.S. Market Size in 2023 | USD 241.13 Million |
| U.S. Market Size by 2033 | USD 476.56 Million |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Devices Type, By Application, and By End-user |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Green Cement Market Size to Attain USD 1,046.76 Million by 2033
The report presents the volume and value-based market size for the base year 2023 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.
Focusing on the global atherectomy devices market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the atherectomy devices market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of atherectomy devices products across different countries and applications.
Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2024 to 2033. It also includes accurate figures for production capacity and production by region during the same period.
The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.
This in-depth research report offers valuable insights into the atherectomy devices market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.
The competitive landscape section of the report provides detailed information on xx market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the atherectomy devices market.
Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Atherectomy Devices Market Companies
- Abbott Laboratories
- Boston Scientific Corporation
- BD
- Cardinal Health Inc.
- Koninklijke Philips NV
- Medtronic Plc
- Terumo Corporation
- Avinger
- Cardiovascular Systems
- Ra Medical Systems
Segments Covered in the Report
By Devices Type
- Atherectomy Devices
- Angioplasty Balloon Catheters
- Stents (Bare-Metal, Drug-Eluting, Bioresorbable)
- Intravascular Ultrasound (IVUS) Catheters
- Optical Coherence Tomography (OCT) Catheters
- Drug-Coated Balloons
- Embolic Protection Devices
- Thrombectomy Devices
- Aortic Stent Grafts
- Endovascular Grafts
- Laser Atherectomy Devices
- Orbital Atherectomy Systems
- Rotational Atherectomy Devices
- Directional Atherectomy Devices
- Chronic Total Occlusion (CTO) Devices
By Application
- Peripheral Artery Disease (PAD) Treatment Devices
- Coronary Artery Disease (CAD) Intervention Devices
- Carotid Artery Disease Intervention Devices
- Renal Artery Disease Intervention Devices
- Aortic Atherosclerosis Intervention Devices
By End-user
- Cardiac Catheterization Labs
- Interventional Radiology Departments
- Vascular Surgery Centers
- Cardiology Clinics
- Academic Research Institutions
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Atherectomy Devices Market
5.1. COVID-19 Landscape: Atherectomy Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Atherectomy Devices Market, By Devices Type
8.1. Atherectomy Devices Market Revenue and Volume, by Devices Type, 2024-2033
8.1.1 Atherectomy Devices
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Angioplasty Balloon Catheters
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Stents (Bare-Metal, Drug-Eluting, Bioresorbable)
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Intravascular Ultrasound (IVUS) Catheters
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Optical Coherence Tomography (OCT) Catheters
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Drug-Coated Balloons
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
8.1.7. Embolic Protection Devices
8.1.7.1. Market Revenue and Volume Forecast (2021-2033)
8.1.8. Thrombectomy Devices
8.1.8.1. Market Revenue and Volume Forecast (2021-2033)
8.1.9. Aortic Stent Grafts
8.1.9.1. Market Revenue and Volume Forecast (2021-2033)
8.1.10. Endovascular Grafts
8.1.10.1. Market Revenue and Volume Forecast (2021-2033)
8.1.11. Laser Atherectomy Devices
8.1.11.1. Market Revenue and Volume Forecast (2021-2033)
8.1.12. Orbital Atherectomy Systems
8.1.12.1. Market Revenue and Volume Forecast (2021-2033)
8.1.13. Rotational Atherectomy Devices
8.1.13.1. Market Revenue and Volume Forecast (2021-2033)
8.1.14. Directional Atherectomy Devices
8.1.14.1. Market Revenue and Volume Forecast (2021-2033)
8.1.15. Chronic Total Occlusion (CTO) Devices
8.1.15.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Atherectomy Devices Market, By Application
9.1. Atherectomy Devices Market Revenue and Volume, by Application, 2024-2033
9.1.1. Peripheral Artery Disease (PAD) Treatment Devices
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Coronary Artery Disease (CAD) Intervention Devices
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Carotid Artery Disease Intervention Devices
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Renal Artery Disease Intervention Devices
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Aortic Atherosclerosis Intervention Devices
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Atherectomy Devices Market, By End-user
10.1. Atherectomy Devices Market Revenue and Volume, by End-user, 2024-2033
10.1.1. Cardiac Catheterization Labs
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Interventional Radiology Departments
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Vascular Surgery Centers
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Cardiology Clinics
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Academic Research Institutions
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Atherectomy Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
Chapter 12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Boston Scientific Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. BD
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cardinal Health Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Koninklijke Philips NV
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Medtronic Plc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Terumo Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Avinger
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Cardiovascular Systems
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Ra Medical Systems
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
